Symmex unveils Huraflow-MES platform to NAFDAC to enhance pharmaceutical oversight and efficiency

Symmex Smart Workings Limited, a technology startup, has introduced its locally developed Huraflow-MES platform to the National Agency for Food and Drug Administration and Control NAFDAC. The company presented the Manufacturing Execution System as part of a proposed collaboration to strengthen Nigeria’s pharmaceutical manufacturing ecosystem, aiming to upgrade regulatory oversight, patient safety, and industrial efficiency in the pharmaceutical and FMCG sectors. Olumide Awoyemi, Founder and Chief Executive Officer of Symmex, stated that Huraflow-MES was developed to digitize Nigeria's manufacturing sector, which largely relies on manual processes, especially in pharmaceuticals. The platform integrates manufacturing elements like materials, machines, manpower, and methods into a unified digital interface for real-time monitoring, traceability, and compliance. Awoyemi noted that the solution addresses limitations faced by regulators like NAFDAC, whose capacity can lag behind industry expansion. It introduces a remote inspection model, allowing regulators to access electronic records before on-site visits, improving efficiency and targeting high-risk areas. The platform also enhances patient safety through tamper-evident audit trails and supports faster product recalls. Symmex is also developing ONÍSÈGÙN AI, a pharmaceutical development platform designed to reduce the time and cost of local drug formulation using artificial intelligence, incorporating Nigeria’s climatic realitie